Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
The role of menin inhibitors in acute myeloid leukemia.
Journal: Current opinion in oncology
Published: August 21, 2025
Menin inhibition for the treatment of acute leukemia.
Journal: Seminars in hematology
Published: July 29, 2025
Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed NPM1-Mutated or KMT2A-Rearranged AML.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 12, 2025
Budget impact analysis of revumenib for the treatment of relapsed or refractory acute leukemias with a KMT2A translocation in the United States.
Journal: Journal of managed care & specialty pharmacy
Published: June 03, 2025
Revumenib for Relapsed or Refractory Acute Leukemia With a KMT2A Translocation.
Journal: The Annals of pharmacotherapy
Published: May 29, 2025
Therapeutic Implications of Menin Inhibitors in the Treatment of Acute Leukemia: A Critical Review.
Journal: Diseases (Basel, Switzerland)
Published: May 22, 2025
Combination Strategies with Menin Inhibitors for Acute Leukemia.
Journal: Blood cancer discovery
Published: May 05, 2025
Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 20, 2025
Advances in menin inhibition in acute myeloid leukemia.
Journal: Trends in cancer
Published: April 15, 2025
Menin inhibitors in KMT2A-rearranged leukemia: Mechanistic insights, clinical trial progress, and potential of combination therapies.
Journal: Leukemia research
Published: April 09, 2025
TP53 Inactivation Confers Resistance to the Menin Inhibitor Revumenib in Acute Myeloid Leukemia.
Journal: bioRxiv : the preprint server for biology
Published: April 08, 2025
Last Updated: 10/31/2025